Lactic acid/citric acid/potassium bitartrate

From Wikipedia, the free encyclopedia

Lactic acid/citric acid/potassium bitartrate
Combination of
Lactic acidAlpha hydroxy acid
Citric acidTricarboxylic acid
Potassium bitartrateSugar acid salt
Clinical data
Trade namesPhexxi
License data
Routes of
administration
Intravaginal
ATC code
  • None
Legal status
Legal status

Lactic acid/citric acid/potassium bitartrate, sold under the brand name Phexxi, is a non-hormonal combination medication used as a method of birth control.[1] It contains lactic acid, citric acid, and potassium bitartrate.[1] It is a gel inserted into the vagina.[1][2]

The most common adverse reactions include vulvovaginal burning sensation, vulvovaginal pruritus, vulvovaginal mycotic infection, urinary tract infection, vulvovaginal discomfort, bacterial vaginosis, vaginal discharge, genital discomfort, dysuria, and vulvovaginal pain.[1]

Medical uses[]

The combination is indicated for the prevention of pregnancy in females of reproductive potential for use as an on-demand method of contraception.[1]

History[]

The combination was approved for medical use in the United States in May 2020.[1][3]

References[]

  1. ^ a b c d e f "U.S. FDA Approves Evofem Biosciences' Phexxi (lactic acid, citric acid and potassium bitartrate), the First and Only Non-Hormonal Prescription Gel for the Prevention of Pregnancy". Evofem Biosciences (Press release). 22 May 2020. Retrieved 22 May 2020 – via PR Newswire.
  2. ^ Steinberg J, Lynch SE (May 2021). "Lactic Acid, Citric Acid, and Potassium Bitartrate (Phexxi) Vaginal Gel for Contraception". American Family Physician. 103 (10): 628–629. PMID 33982994.
  3. ^ "Phexxi: FDA-Approved Drugs". U.S. Food and Drug Administration (FDA). Retrieved 23 May 2020.

External links[]


Retrieved from ""